Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Cash from Financing Activities (2016 - 2026)

Cumberland Pharmaceuticals' Cash from Financing Activities history spans 16 years, with the latest figure at -$681738.0 for Q4 2025.

  • On a quarterly basis, Cash from Financing Activities rose 50.54% to -$681738.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$6.7 million, a 3525.79% decrease, with the full-year FY2025 number at -$6.7 million, down 3525.79% from a year prior.
  • Cash from Financing Activities hit -$681738.0 in Q4 2025 for Cumberland Pharmaceuticals, down from -$386879.0 in the prior quarter.
  • Over the last five years, Cash from Financing Activities for CPIX hit a ceiling of $3.9 million in Q1 2022 and a floor of -$5.5 million in Q1 2025.
  • Historically, Cash from Financing Activities has averaged -$979420.0 across 5 years, with a median of -$1.0 million in 2022.
  • The widest YoY moves for Cash from Financing Activities: up 401.86% in 2022, down 619.86% in 2022.
  • Tracing CPIX's Cash from Financing Activities over 5 years: stood at -$735300.0 in 2021, then plummeted by 278.19% to -$2.8 million in 2022, then surged by 46.52% to -$1.5 million in 2023, then increased by 7.31% to -$1.4 million in 2024, then soared by 50.54% to -$681738.0 in 2025.
  • Business Quant data shows Cash from Financing Activities for CPIX at -$681738.0 in Q4 2025, -$386879.0 in Q3 2025, and -$150797.0 in Q2 2025.